Despite the presence of some well-defined trends, a more detailed analysis of CD4+, CD8+, and CD19+ lymphocyte subpopulations did not highlight additional differences between the two cohorts of CVID patients (see Fig. S2 in this article’s Online Resource). This evidence concerns the gene CD4 and common variable immunodeficiency.